Speaking of Science

» HIV, art, disease/medicine and science policy

Most Recent

image: Notable Science Quotes

Notable Science Quotes

By | June 1, 2016

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

image: Speaking of Science

Speaking of Science

By | May 1, 2016

May 2016's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | February 1, 2016

February 2016's selection of notable quotes

1 Comment

image: Speaking of Science

Speaking of Science

By | January 1, 2016

January 2016's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | December 1, 2015

December 2015's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | October 1, 2015

October 2015's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | August 1, 2015

August 2015's selection of notable quotes

5 Comments

image: Speaking of Science

Speaking of Science

By | May 1, 2015

May 2015's selection of notable quotes

1 Comment

image: Speaking of Science

Speaking of Science

By | February 1, 2015

February 2015's selection of notable quotes

0 Comments

image: Speaking of Science

Speaking of Science

By | December 1, 2014

December 2014's selection of notable quotes

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech